EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hybrid Membrane‐Coated Nanoparticles for Precise Targeting and Synergistic Therapy in Alzheimer's Disease

Rong-Rong Lin, Lu-Lu Jin, Yan-Yan Xue, Zhe-Sheng Zhang, Hui-Feng Huang, Dian-Fu Chen, Qian Liu, Zheng-Wei Mao, Zhi-Ying Wu iD, Qing-Qing Tao

Advanced Science · 2024-06 · 11 (24)

DOI: 10.1002/advs.202306675 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 22.04.2024. Verfasst von Rong-Rong Lin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Research Center of Neurology in Second Affiliated Hospital, and Liangzhu Laboratory, Zhejiang University School of Medici…. Hauptthemen laut MEDLINE: Alzheimer Disease, Nanoparticles, Disease Models, Animal, Mice, Transgenic. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science Innovation 2030-Brain Science and Brain-Inspired Intelligence Technology Major Projects, Key R&D Program of Zhejiang Province, Natural Science Foundation of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The blood brain barrier (BBB) limits the application of most therapeutic drugs for neurological diseases (NDs). Hybrid cell membrane‐coated nanoparticles derived from different cell types can mimic the surface properties and functionalities of the source cells, further enhancing their targeting precision and therapeutic efficacy. Neuroinflammation has been increasingly recognized as a critical factor in the pathogenesis of various NDs, especially Alzheimer's disease (AD). In this study, a novel cell membrane coating is designed by hybridizing the membrane from platelets and chemokine (C–C motif) receptor 2 (CCR2) cells are overexpressed to cross the BBB and target neuroinflammatory lesions. Past unsuccessful endeavors in AD drug development underscore the challenge of achieving favorable outcomes when utilizing single‐mechanism drugs.Two drugs with different mechanisms of actions into liposomes are successfully loaded to realize multitargeting treatment. In a transgenic mouse model for familial AD (5xFAD), the administration of these drug‐loaded hybrid cell membrane liposomes results in a significant reduction in amyloid plaque deposition, neuroinflammation, and cognitive impairments. Collectively, the hybrid cell membrane‐coated nanomaterials offer new opportunities for precise drug delivery and disease‐specific targeting, which represent a versatile platform for targeted therapy in AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseNanoparticlesDisease Models, AnimalMice, TransgenicBlood-Brain BarrierLiposomesAnimalsMiceDrug Delivery SystemsCell MembraneHumans

Stichwörter der Autor:innen

Alzheimer's diseasehybrid cell membrane‐coated liposomesinflammatory targetingsynergistic therapy

Substanzen

Liposomes

Autor:innen und Institutionen

  • Department of Neurology and Research Center of Neurology in Second Affiliated Hospital, and Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, 310009, China.
  • MOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, 310027, China.
  • MOE Frontier Science Center for Brain Science and Brain-Machine Integration, School of Brain Science and Brain Medicine, Zhejiang University, Hangzhou, 310058, China.
  • CAS Center for Excellence in Brain Science and Intelligence Technology, Shanghai, 200031, China.

ORCID-Profile: Zhi-Ying Wu

Förderung

  • Science Innovation 2030-Brain Science and Brain-Inspired Intelligence Technology Major Projects
  • Key R&D Program of Zhejiang Province
  • Natural Science Foundation of Zhejiang Province
  • Key Science & Technologies R&D Program of Lishui City

Zitieren

APA

Lin, R. R., Jin, L. L., Xue, Y. Y., Zhang, Z. S., Huang, H. F., Chen, D. F., Liu, Q., Mao, Z. W., Wu, Z. Y., & Tao, Q. Q. (2024). Hybrid Membrane‐Coated Nanoparticles for Precise Targeting and Synergistic Therapy in Alzheimer's Disease. Advanced Science, 11(24). https://doi.org/10.1002/advs.202306675

Vancouver

Lin RR, Jin LL, Xue YY, Zhang ZS, Huang HF, Chen DF, et al. Hybrid Membrane‐Coated Nanoparticles for Precise Targeting and Synergistic Therapy in Alzheimer's Disease. Advanced Science. 2024;11(24). doi:10.1002/advs.202306675

BibTeX
@article{Lin2024,
  author = {Lin, Rong-Rong and Jin, Lu-Lu and Xue, Yan-Yan and Zhang, Zhe-Sheng and Huang, Hui-Feng and Chen, Dian-Fu and Liu, Qian and Mao, Zheng-Wei and Wu, Zhi-Ying and Tao, Qing-Qing},
  title = {Hybrid Membrane‐Coated Nanoparticles for Precise Targeting and Synergistic Therapy in Alzheimer's Disease},
  journal = {Advanced Science},
  year = {2024},
  volume = {11},
  number = {24},
  doi = {10.1002/advs.202306675}
}
Kostenlos starten →